Literature DB >> 22302035

Lyn kinase controls TLR4-dependent IKK and MAPK activation modulating the activity of TRAF-6/TAK-1 protein complex in mast cells.

Martin Avila1, Adriana Martinez-Juarez, Alfredo Ibarra-Sanchez, Claudia Gonzalez-Espinosa.   

Abstract

Mast cells (MCs) control allergic reactions and contribute to protective innate immune responses through TLR4 activation. The tyrosine kinase Lyn is important to the high affinity IgE receptor (FcεRI) signal transduction system in MCs, but its role on the TLR4 signalling cascade is still elusive. Here, we characterized several TLR4-triggered responses in bone marrow-derived mast cells (BMMCs) from wild-type (WT) and Lyn(-/-) mice. We found that Lyn(-/-) MCs secreted lower amounts of TNF-α after LPS challenge when compared with WT cells. Lyn(-/-) BMMCs showed less MAPK, IκB phosphorylation and NF-κB nuclear translocation after TLR-4 triggering than WT cells. LPS-induced MAPK and inhibitor of IκB kinase (IKK) phosphorylation were importantly reduced in the absence of Lyn. A constitutive interaction between TNF receptor associated factor 6 (TRAF-6) and phosphorylated TGF-β-activated kinase (TAK-1) was observed in Lyn(-/-) BMMCs and this complex was insensitive to LPS addition. Lyn kinase was activated and associated to TRAF-6 shortly after LPS addition in WT MCs. Analyzing two local MC-dependent innate immune responses in vivo, we found that Lyn positively controls early TNF-α production and immune cell recruitment after an intraperitoneal injection of LPS. Our results indicate that Lyn plays a positive role in TLR4-induced production of TNF-α in MCs controlling the activity of the TRAF-6/TAK-1 protein complex.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22302035     DOI: 10.1177/1753425911435265

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  28 in total

1.  Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization.

Authors:  Xianjing Li; Zhuo Wang; Yulian Zou; Ermei Lu; Jingjing Duan; Hongbao Yang; Qijin Wu; Xiaona Zhao; Yun Wang; Linjun You; Ling He; Tao Xi; Yong Yang
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

2.  Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses.

Authors:  Jonathon Mitchell; Su Jin Kim; Alexandra Seelmann; Brendan Veit; Brooke Shepard; Eunok Im; Sang Hoon Rhee
Journal:  Biochem Pharmacol       Date:  2017-11-23       Impact factor: 5.858

Review 3.  Tyrosine phosphorylation in Toll-like receptor signaling.

Authors:  Saurabh Chattopadhyay; Ganes C Sen
Journal:  Cytokine Growth Factor Rev       Date:  2014-06-21       Impact factor: 7.638

4.  Effect of TRAF6 on the biological behavior of human lung adenocarcinoma cell.

Authors:  Lou Zhong; Fei Cao; Qingsheng You
Journal:  Tumour Biol       Date:  2012-10-04

5.  Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation.

Authors:  F Guzmán-Mejía; C López-Rubalcava; C González-Espinosa
Journal:  J Neuroimmune Pharmacol       Date:  2017-08-18       Impact factor: 4.147

6.  Novel phosphatidylethanolamine derivatives accumulate in circulation in hyperlipidemic ApoE-/- mice and activate platelets via TLR2.

Authors:  Sudipta Biswas; Liang Xin; Soumya Panigrahi; Alejandro Zimman; Hua Wang; Valentin P Yakubenko; Tatiana V Byzova; Robert G Salomon; Eugene A Podrez
Journal:  Blood       Date:  2016-03-25       Impact factor: 22.113

7.  Bioactive hyaluronic acid fragments inhibit lipopolysaccharide-induced inflammatory responses via the Toll-like receptor 4 signaling pathway.

Authors:  Na You; Sasa Chu; Binggang Cai; Youfang Gao; Mizhou Hui; Jin Zhu; Maorong Wang
Journal:  Front Med       Date:  2020-09-18       Impact factor: 4.592

8.  Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal.

Authors:  Sarmishtha De; Hao Zhou; David DeSantis; Colleen M Croniger; Xiaoxia Li; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-20       Impact factor: 11.205

9.  TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell.

Authors:  Qingbing Meng; Minqian Zheng; Hongbing Liu; Changzhi Song; Wensheng Zhang; Juan Yan; Ling Qin; Xiaolan Liu
Journal:  Mol Cell Biochem       Date:  2012-08-12       Impact factor: 3.396

10.  Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation.

Authors:  Chrystelle Lamagna; Patrizia Scapini; Jessica A van Ziffle; Anthony L DeFranco; Clifford A Lowell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.